| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0169-409X(00)00052-1 |
| P698 | PubMed publication ID | 10942813 |
| P2093 | author name string | Noble MD | |
| Tresco PA | |||
| Biran R | |||
| P2860 | cites work | Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure | Q24634002 |
| Transplantation of Chondrocytes Utilizing a Polymer-Cell Construct to Produce Tissue-Engineered Cartilage in the Shape of a Human Ear | Q28246001 | ||
| Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients | Q28279918 | ||
| Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy | Q28297851 | ||
| Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts--an alternate approach to somatic gene therapy | Q28300694 | ||
| In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector | Q29547503 | ||
| Autogenous tissue-engineered cartilage: evaluation as an implant material | Q30472258 | ||
| Targeting of an inducible toxic phenotype in animal cells | Q33654882 | ||
| Encapsulation for somatic gene therapy | Q33692528 | ||
| Genetically engineered pancreatic beta-cell lines for cell therapy of diabetes. | Q33692590 | ||
| Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson’s disease in rats | Q33745707 | ||
| Approaches to the management of postprandial hyperglycaemia | Q33752351 | ||
| Gene therapy for long-term expression of erythropoietin in rats | Q34026743 | ||
| Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results | Q34068061 | ||
| A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium | Q34254567 | ||
| Encapsulated PC12 cell transplants into hemiparkinsonian monkeys: a behavioral, neuroanatomical, and neurochemical analysis | Q42486461 | ||
| Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain | Q42504905 | ||
| Effects of intraventricular encapsulated hNGF-secreting fibroblasts in aged rats. | Q42519480 | ||
| In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors | Q42818740 | ||
| Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase | Q43185222 | ||
| Amendment to Clinical Research Project. Project 90-C-195. April 1, 1993. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with autologous lymphocytes transduced with a human ADA gene. | Q43504496 | ||
| Long-term restoration of striatal L-aromatic amino acid decarboxylase activity using recombinant adeno-associated viral vector gene transfer in a rodent model of Parkinson's disease | Q43535625 | ||
| Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors | Q43716886 | ||
| A Metabolically Active Human Dermal Replacement for the Treatment of Diabetic Foot Ulcers | Q43757230 | ||
| Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts | Q44203713 | ||
| The olfactory nerve contains two populations of glia, identified both in vivo and in vitro | Q44463553 | ||
| Characterization of Intrastriatal Recombinant Adeno-Associated Virus-Mediated Gene Transfer of Human Tyrosine Hydroxylase and Human GTP-Cyclohydrolase I in a Rat Model of Parkinson’s Disease | Q45756120 | ||
| Recombinant adeno-associated virus for muscle directed gene therapy | Q45764433 | ||
| Astrocyte-specific expression of tyrosine hydroxylase after intracerebral gene transfer induces behavioral recovery in experimental parkinsonism | Q45856399 | ||
| Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients | Q45866834 | ||
| T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. | Q45866838 | ||
| Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease | Q45876215 | ||
| Tissue-engineered skeletal muscle organoids for reversible gene therapy | Q45879827 | ||
| Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors | Q45881242 | ||
| In vivo expression and survival of gene-modified T lymphocytes in rhesus monkeys | Q45881711 | ||
| Nonviral strategies for gene therapy | Q45881959 | ||
| Gene therapy - promises, problems and prospects | Q45883584 | ||
| Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors | Q45884182 | ||
| A Gene Therapy Approach to Regulated Delivery of Erythropoietin as a Function of Oxygen Tension | Q45884448 | ||
| Constitutive Expression of phVEGF 165 After Intramuscular Gene Transfer Promotes Collateral Vessel Development in Patients With Critical Limb Ischemia | Q45886388 | ||
| Glial-Restricted Precursors Are Derived from Multipotent Neuroepithelial Stem Cells | Q73561463 | ||
| Isolation of Lineage-Restricted Neuronal Precursors from Multipotent Neuroepithelial Stem Cells | Q73838047 | ||
| Long-Term Erythropoietin Expression in Rodents and Non-Human Primates Following Intramuscular Injection of a Replication-Defective Adenoviral Vector | Q73848486 | ||
| A completely biological tissue-engineered human blood vessel | Q74075096 | ||
| Expansion of Functional Adult Porcine Islet Cells in Vitro Using Purified Laminin 5 | Q74414483 | ||
| Tissue engineered neocartilage using plasma derived polymer substrates and chondrocytes | Q74534448 | ||
| Regenerative signals for tissue-engineered small intestine | Q74616546 | ||
| Encapsulated cells as therapy | Q77317738 | ||
| Bioreactor perfusion system for the long-term maintenance of tissue-engineered skeletal muscle organoids | Q77483244 | ||
| Purification and characterization of astrocyte precursor cells in the developing rat optic nerve | Q77911389 | ||
| Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges | Q38555125 | ||
| Design of nasoseptal cartilage replacements synthesized from biodegradable polymers and chondrocytes | Q38570551 | ||
| Neuronal stem cells in the brain of adult vertebrates | Q40445989 | ||
| Non-viral gene therapy | Q40535778 | ||
| Treatment of amyotrophic lateral sclerosis using a gene therapy approach | Q40553975 | ||
| Symbiosis of biotechnology and biomaterials: applications in tissue engineering of bone and cartilage | Q40575706 | ||
| Recent progress in immunoisolated cell therapy | Q40575713 | ||
| Nonviral gene therapy: the promise of genes as pharmaceutical products | Q40926330 | ||
| Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis | Q40935559 | ||
| Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transplantable human neural stem cell lines by epigenetic stimulation | Q40962528 | ||
| Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor. | Q40983409 | ||
| Dopamine turnover and metabolism in the striatum of parkinsonian rats grafted with genetically-modified human astrocytes | Q41035398 | ||
| Cellular Delivery of Cntf but not Nt-4/5 Prevents Degeneration of Striatal Neurons in a Rodent Model of Huntington's Disease | Q41042641 | ||
| Therapeutic potential of a polymer-encapsulated L-DOPA and dopamine-producing cell line in rodent and primate models of Parkinson's disease. | Q41042658 | ||
| Synergistic but transient rescue effects of BDNF and GDNF on axotomized neonatal motoneurons | Q41055614 | ||
| Tissue Engineered Skeletal Muscle: Preparation of Highly Dense, Highly Oriented Hybrid Muscular Tissues | Q41061711 | ||
| Delivery of Recombinant Gene Product to Canines with Nonautologous Microencapsulated Cells | Q41064182 | ||
| Implants of Polymer-Encapsulated Genetically Modified Cells Releasing Glial Cell Line-Derived Neurotrophic Factor Improve Survival, Growth, and Function of Fetal Dopaminergic Grafts | Q41067317 | ||
| Transplantation of a polymer-encapsulated cell line genetically engineered to release NGF. | Q41074833 | ||
| Xenotransplantation of Transgenic Oligodendrocyte-Lineage Cells into Spinal Cord-Injured Adult Rats | Q41091182 | ||
| Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vector-corrected fibroblasts secreting high levels of β-glucuronidase | Q41102578 | ||
| Vertebrate neural progenitor cells: subtypes and regulation | Q41103224 | ||
| Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington's disease | Q41113101 | ||
| Isolation, cloning and characterization of a putative type-1 astrocyte cell line | Q41116698 | ||
| Stem cells in the central nervous system | Q41116811 | ||
| Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease | Q41120174 | ||
| Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblasts | Q41158860 | ||
| Current status of CF gene therapy | Q41161867 | ||
| Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease | Q41175238 | ||
| Polymer-encapsulated genetically modified cells continue to secrete human nerve growth factor for over one year in rat ventricles: behavioral and anatomical consequences | Q41182548 | ||
| Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF. | Q41200392 | ||
| Intrastriatal implants of polymer encapsulated cells genetically modified to secrete human nerve growth factor: trophic effects upon cholinergic and noncholinergic striatal neurons | Q41201451 | ||
| Expression of human beta-hexosaminidase alpha-subunit gene (the gene defect of Tay-Sachs disease) in mouse brains upon engraftment of transduced progenitor cells | Q41212883 | ||
| Polymer Encapsulated Cell Lines Genetically Engineered to Release Ciliary Neurotrophic Factor Can Slow Down Progressive Motor Neuronopathy in the Mouse | Q41341467 | ||
| Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms | Q41365447 | ||
| Delivery of neurotrophic factors to the CNS using encapsulated cells: developing treatments for neurodegenerative diseases. | Q41392774 | ||
| Polymer-encapsulated Schwannoma cells expressing human nerve growth factor promote the survival of cholinergic neurons after a fimbria-fornix transection | Q41396175 | ||
| Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons | Q41433192 | ||
| Purified astrocytes promote the in vitro division of a bipotential glial progenitor cell | Q41581099 | ||
| Drug delivery to the nervous system | Q41627280 | ||
| In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium | Q41644008 | ||
| POLYMER-ENCAPSULATED PC12 CELLS: LONG-TERM SURVIVAL AND ASSOCIATED REDUCTION IN LESION-INDUCED ROTATIONAL BEHAVIOR. | Q41644213 | ||
| Sustained proliferation of PDX-1+ cells derived from human islets | Q41665643 | ||
| Novel therapeutic directions for Parkinson's disease | Q41671598 | ||
| Long-term cross-species brain transplantation of a polymer-encapsulated dopamine-secreting cell line | Q41692307 | ||
| Intracerebral implantation of nerve growth factor-producing fibroblasts protects striatum against neurotoxic levels of excitatory amino acids | Q41704517 | ||
| Cerebral white matter contains PDGF-responsive precursors to O2A cells | Q41731670 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. | Q42483788 | ||
| A proliferative adult human oligodendrocyte progenitor | Q34311928 | ||
| Long-term expression of human adenosine deaminase in mice transplanted with retrovirus-infected hematopoietic stem cells | Q34319569 | ||
| Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease | Q34320662 | ||
| Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans | Q34345458 | ||
| Polyamidoamine cascade polymers mediate efficient transfection of cells in culture | Q34347285 | ||
| Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression | Q34615481 | ||
| Expression of the human cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer | Q35072251 | ||
| Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons | Q35107162 | ||
| Long-term regulated expression of growth hormone in mice after intramuscular gene transfer | Q35559776 | ||
| A novel approach to neural transplantation in Parkinson's disease: use of polymer-encapsulated cell therapy | Q35655515 | ||
| The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor | Q35884401 | ||
| A tripotential glial precursor cell is present in the developing spinal cord | Q36015628 | ||
| Electroporation for the efficient transfection of mammalian cells with DNA. | Q36117404 | ||
| Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia | Q36150259 | ||
| Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes | Q36156054 | ||
| Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus | Q36159178 | ||
| "Global" cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain | Q36389958 | ||
| Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo | Q36457858 | ||
| Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. | Q36561684 | ||
| Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector | Q36586077 | ||
| Transplanted Olfactory Ensheathing Cells Remyelinate and Enhance Axonal Conduction in the Demyelinated Dorsal Columns of the Rat Spinal Cord | Q37019984 | ||
| Transduction of a foreign histocompatibility gene into the arterial wall induces vasculitis | Q37046887 | ||
| Review: Tissue engineering in the nervous system | Q37211976 | ||
| Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo | Q37300317 | ||
| Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis | Q37353301 | ||
| Targeted and nontargeted liposomes for in vivo transfer to rat liver cells of a plasmid containing the preproinsulin I gene | Q37508435 | ||
| Transferrin gene expression visualized in oligodendrocytes of the rat brain by using in situ hybridization and immunohistochemistry | Q37551446 | ||
| Adenovirus enhancement of transferrin-polylysine-mediated gene delivery | Q37603166 | ||
| Biomaterials in Tissue Engineering | Q38294476 | ||
| Tissue-engineered nipple reconstruction | Q38548365 | ||
| Formation of spheroidal aggregates of hepatocytes on biodegradable polymers under continuous-flow bioreactor conditions | Q38549541 | ||
| Chondrogenesis in a cell-polymer-bioreactor system | Q38552139 | ||
| Creation Of Viable Pulmonary Artery Autografts Through Tissue Engineering | Q38552626 | ||
| Encapsulated cell technology | Q45887969 | ||
| Intrathecal implants of bovine chromaffin cells alleviate mechanical allodynia in a rat model of neuropathic pain | Q45888753 | ||
| Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. | Q45890216 | ||
| Cationic liposome-mediated transfection. | Q45997090 | ||
| Systemic Gene Expression After Intravenous DNA Delivery into Adult Mice | Q46128630 | ||
| Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. | Q46187210 | ||
| Behavioral recovery following intrastriatal implantation of microencapsulated PC12 cells | Q46234690 | ||
| In vitro toxicity of various classes of test agents using the neutral red assay on a human three-dimensional physiologic skin model | Q46525835 | ||
| Skeletal myogenesis on elastomeric substrates: implications for tissue engineering | Q47758042 | ||
| Growth and Fate of PSA-NCAM+ Precursors of the Postnatal Brain | Q47812503 | ||
| Neurotrophin-3 and Brain-Derived Neurotrophic Factor Induce Oligodendrocyte Proliferation and Myelination of Regenerating Axons in the Contused Adult Rat Spinal Cord | Q47892533 | ||
| A role for platelet-derived growth factor in normal gliogenesis in the central nervous system | Q48087702 | ||
| Isolation and intracerebral grafting of nontransformed multipotential embryonic human CNS stem cells | Q48097963 | ||
| In vitro expansion of a multipotent population of human neural progenitor cells | Q48156909 | ||
| Polymer-encapsulated PC12 cells promote recovery of motor function in aged rats | Q48257708 | ||
| A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes | Q48413417 | ||
| Polymer-Encapsulated PC-12 Cells Demonstrate High-Affinity Uptake of Dopamine in Vitro and 18F-DOPA Uptake and Metabolism after Intracerebral Implantation in Nonhuman Primates | Q48618232 | ||
| Experiments in a Parkinson's Rat Model | Q48656474 | ||
| Cellular Delivery of NGF Does Not Alter the Expression of β-Amyloid Immunoreactivity in Young or Aged Nonhuman Primates | Q48691983 | ||
| Somatic delivery of catecholamines in the striatum attenuate parkinsonian symptoms and widen the therapeutic window of oral sinemet in rats | Q48713866 | ||
| Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. | Q48857343 | ||
| Neural tissue engineering: from polymer to biohybrid organs | Q49135509 | ||
| Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor. | Q49159036 | ||
| Comparative study of the use of poly(glycolic acid), calcium alginate and pluronics in the engineering of autologous porcine cartilage | Q51513274 | ||
| High-dose biotin, an inducer of glucokinase expression, may synergize with chromium picolinate to enable a definitive nutritional therapy for type II diabetes | Q51562184 | ||
| Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture | Q52251326 | ||
| Deformation of articular cartilage collagen structure under static and cyclic loading | Q52981337 | ||
| Dystrophin expression improves myofiber survival in mdx muscle following intramuscular plasmid DNA injection | Q53950756 | ||
| Rescue of motoneurons from axotomy-induced cell death by polymer encapsulated cells genetically engineered to release CNTF | Q56947142 | ||
| De novo reconstitution of a functional mammalian urinary bladder by tissue engineering | Q57395958 | ||
| Repair of demyelinated lesions by transplantation of purified 0-2A progenitor cells | Q59079119 | ||
| Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs | Q59080986 | ||
| Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor ceil | Q59093382 | ||
| Collagen in tissue-engineered cartilage: Types, structure, and crosslinks | Q59125604 | ||
| The in vitro construction of a tissue engineered bioprosthetic heart valve | Q60143429 | ||
| Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice | Q64377665 | ||
| Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: a phase I clinical trial | Q64382613 | ||
| Astrocyte precursors in neonatal rat spinal cord cultures | Q68172613 | ||
| Transplantation of neural tissue in polymer capsules | Q68389570 | ||
| Plasmid DNA adsorbed to pH-sensitive liposomes efficiently transforms the target cells | Q69416798 | ||
| Two types of astrocytes in cultures of developing rat white matter: differences in morphology, surface gangliosides, and growth characteristics | Q70257797 | ||
| Long-term secretion of therapeutic proteins from genetically modified skeletal muscles | Q71577331 | ||
| Femoral shaft reconstruction using tissue-engineered growth of bone | Q71688811 | ||
| Immunoisolated xenogenic chromaffin cell therapy for chronic pain. Initial clinical experience | Q71775473 | ||
| Transplants of immunologically isolated xenogeneic chromaffin cells provide a long-term source of pain-reducing neuroactive substances | Q72082043 | ||
| Neural stem cells in the adult mammalian forebrain: a relatively quiescent subpopulation of subependymal cells | Q72769766 | ||
| Intrastriatal implants of polymer-encapsulated PC12 cells: effects on motor function in aged rats | Q72837330 | ||
| Lineage-restricted neural precursors can be isolated from both the mouse neural tube and cultured ES cells | Q73003922 | ||
| Bcl-2: Prolonging Life in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis | Q73520806 | ||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3-27 | |
| P577 | publication date | 2000-08-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Advanced Drug Delivery Reviews | Q2825362 |
| P1476 | title | Cellular transplants as sources for therapeutic agents | |
| P478 | volume | 42 |
| Q37845396 | Drug delivery strategies for therapeutic angiogenesis and antiangiogenesis |
| Q40700070 | Hollow fiber membrane diffusive permeability regulates encapsulated cell line biomass, proliferation, and small molecule release |
| Q34769911 | Potential new methods for antiepileptic drug delivery |
| Q36474284 | Principles and applications of cell delivery systems for periodontal regeneration. |
| Q37449255 | Self-healing polysaccharide-based hydrogels as injectable carriers for neural stem cells |
| Q34291761 | Thyrocyte integration, and thyroid folliculogenesis and tissue regeneration: perspective for thyroid tissue engineering |
| Q40616138 | Transplantation of glial cell line‐derived neurotrophic factor‐expressing cells into the striatum and nucleus accumbens attenuates acquisition of cocaine self‐administration in rats |
Search more.